118 related articles for article (PubMed ID: 16515264)
1. [Chronic hepatitis B: from old braids and new brooms].
Krankenpfl J; 2005; 43(7-10):192-3. PubMed ID: 16515264
[No Abstract] [Full Text] [Related]
2. Chronic hepatitis B--new goals, new treatment.
Lai CL; Yuen MF
N Engl J Med; 2008 Dec; 359(23):2488-91. PubMed ID: 19052131
[No Abstract] [Full Text] [Related]
3. Hepatitis B virus with primary resistance to adefovir.
Chang TT; Lai CL
N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
[No Abstract] [Full Text] [Related]
4. Adefovir for lamivudine resistant HBV: more than meets the eye.
Di Marco V; Craxì A
J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
[No Abstract] [Full Text] [Related]
5. Suppressing hepatitis B without resistance--so far, so good.
Mailliard ME; Gollan JL
N Engl J Med; 2003 Feb; 348(9):848-50. PubMed ID: 12606741
[No Abstract] [Full Text] [Related]
6. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
Mohamadnejad M
Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389
[No Abstract] [Full Text] [Related]
7. Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases?
Nguyen MH; Keeffe EB
Clin Infect Dis; 2008 Nov; 47(10):1312-4. PubMed ID: 18840075
[No Abstract] [Full Text] [Related]
8. [The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].
DING JG; SUN QF; FU RQ; WU YH; HONG L
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):387-8. PubMed ID: 19497209
[No Abstract] [Full Text] [Related]
9. Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.
Gallego A; Sheldon J; García-Samaniego J; Margall N; Romero M; Hornillos P; Soriano V; Enrĺquez J
J Viral Hepat; 2008 May; 15(5):392-8. PubMed ID: 18221300
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy for chronic hepatitis B: a one-two knockout punch, or a swing and a miss?
Chun S; Zucker SD
Gastroenterology; 2006 Feb; 130(2):613-4; discussion 514-5. PubMed ID: 16472619
[No Abstract] [Full Text] [Related]
11. First report of genotypic resistance to adefovir in chronic HBV in the Republic of Ireland.
Laoi BN; Herra C; Norris S; Crowley B
J Antimicrob Chemother; 2006 May; 57(5):1009-10. PubMed ID: 16524892
[No Abstract] [Full Text] [Related]
12. Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?
Thio CL
J Hepatol; 2006 Jan; 44(1):1-3. PubMed ID: 16293338
[No Abstract] [Full Text] [Related]
13. [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].
Yang F; Wu XF; Wei N
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):65-6. PubMed ID: 20128975
[No Abstract] [Full Text] [Related]
14. Summaries for patients. Antiviral therapy for chronic hepatitis B.
Ann Intern Med; 2007 Dec; 147(11):I16. PubMed ID: 17909200
[No Abstract] [Full Text] [Related]
15. Hepatitis B genotypes and response to adefovir treatment in patients with HBV chronic infection.
Scotto G; Fazio V
J Infect; 2010 May; 60(5):399-401. PubMed ID: 20226208
[No Abstract] [Full Text] [Related]
16. [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].
MMW Fortschr Med; 2008 May; 150(21):43. PubMed ID: 18578068
[No Abstract] [Full Text] [Related]
17. Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy.
Reijnders JG; Pas SD; Schutten M; de Man RA; Janssen HL
J Hepatol; 2009 Apr; 50(4):674-83. PubMed ID: 19231002
[TBL] [Abstract][Full Text] [Related]
18. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
Dai CY; Chuang WL; Hsieh MY; Lee LP; Huang JF; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
[TBL] [Abstract][Full Text] [Related]
19. Does the presence of adefovir-resistant variants lead to failure of tenofovir monotherapy?
Deterding K; Manns MP; Wedemeyer H
J Hepatol; 2008 Nov; 49(5):862-3. PubMed ID: 18804309
[No Abstract] [Full Text] [Related]
20. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
